Skip Navigation


Annals of Oncology Advance Access originally published online on July 19, 2005
Annals of Oncology 2005 16(12):1979; doi:10.1093/annonc/mdi386
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
16/12/1979    most recent
mdi386v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Smorenburg, C. H.
Right arrow Articles by ten Tije, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smorenburg, C. H.
Right arrow Articles by ten Tije, A. J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 European Society for Medical Oncology

Letter to the Editor

Reply to "Weekly paclitaxel as first-line chemotherapy in elderly advanced breast cancer patients: a phase II study of the Gruppo Italiano di Oncologia Geriatrica (GIOGer)" by L. Del Mastro et al. (Ann Oncol 2005; 16: 253–258)

The first 10% of the full text of this article appears below.

As only few studies have investigated the efficacy and feasibility of chemotherapy in elderly cancer patients, the study by Del . . . [Full Text of this Article]

C. H. Smorenburg1,* and A. J. ten Tije2

1 Vrije Universiteit Medisch Centrum, Amsterdam; 2 Ziekenhuis Gooi-Noord, Blaricum, The Netherlands

* E-mail: smorenburg@vumc.nl


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?